Order, please. I'd like to welcome everyone to the 14th meeting of the Standing Committee on Health. Pursuant to Standing Order 108(2), we are doing a study on post-market surveillance of pharmaceutical products.
Today we have a full complement of presenters, and we have a full complement of questions for all our presenters. We will give each organization 10 minutes to present. Following that, we will go into the questions and answers.
From Health Canada, we have Mr. Michael Vandergrift, Dr. Marc Berthiaume, Dr. David Clapin, and Mr. David Lee; from the Public Health Agency of Canada, Dr. Barbara Law; and from the Ontario Ministry of Health and Long-Term Care, Mr. Brent Fraser. Also on the list we have Dr. Bruce Carleton from the University of British Columbia. Welcome.
I will ask each organization to take 10 minutes. We look forward to hearing from you.
We will begin with Dr. Michael Vandergrift.